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ABSTRACT 
Purpose: To investigate the possible mechanisms of neuronal cell death and the 
neuroprotective and regenerative effect of each neurotrophic factors in advanced 
glycation end-products (AGEs) exposed retinas. 
Methods: Retinal explants of 12 adult SD rats were three-dimensionally cultured 
in collagen gel, and incubated in (1) serum-free control culture media, (2) 10 μg/ 
ml glucose-AGE-BSA (CycLex Co., Ltd., Nagano, Japan) media, (3) 10 μg/ml 
glycolaldehyde-AGE-BSA (CycLex Co) media, (4) 10 μg/ml 
glyceraldehyde-AGE-BSA (CycLex Co.) media, (5) 10 μg/ml 
glucose-AGE-BSAþ100 ng/ml NT-4 (R and D Systems, Minneapolis, MN) 
media, (6) 10μg/ml glycolaldehyde-AGE- BSAþ100 ng/ml NT-4 media, (7) 10 
μg/ml glyceraldehyde-AGE- BSAþ100 ng/ml NT-4 supplemented culture media, 
(8) 100 ng/ ml NT-4 supplemented media without AGE-BSA, or (9) 10 μg/ml 
glucose-AGE-BSAþ 2 μM caspase-9 inhibitor (Z-LEHD-FMK; WAKO, Osaka, 
Japan) supplemented culture media. The 10 μg/ml glycated BSA was selected to 
investigate the effect of a very low dose of AGEs on neurite regeneration. For 
examining the dose- dependent effect of each AGE-BSA on neuronal cell death 
and neurite regeneration, (9) 100 μg/ml glucose-AGE-BSA, (10) 100 μg/ml 
glycolaldehyde-AGE-BSA, or (11) 100 μg/ml glyceraldehyde-AGE- BSA were 
incubated in serum-free media. To investigate the neurotprophic effect of 
different neurotrophic factors (12) glucose +100 ng/ml neurotrophin 4 (NT-4) 
media; (13) glucose +100 ng/ml hepatocyte growth factor (HGF) media; (14) 
glucose +100 ng/ml glial cell line derived neurotrophic factor (GDNF) media; or 
(15) glucose +100 ng/ml tauroursodeoxycholic acid (TUDCA) media were 
studied. The number of regenerating neurites was counted under a 
phase-contrast microscope after 7 days of culture. The explants were 
immunostained for caspase-9, AIF, NFkB, SP1 after 7 days of culture.  
Statistical analyses were performed by one-way ANOVA. 
Results: In retinas incubated with AGEs, the numbers of regenerating neuritis 
were fewer than in control. Neurotrophic factors increased the number of 
neurites, but more significantly in the NT-4 group.  The number of 
TUNEL-positive cells was significantly higher than in control media both in low 
dose sdtudy and high dose study. Caspase-9- and apoptosis inducing factor 
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immunopositive cells was significantly higher than in control media. 
Neurotrophin-4 supplementation increased the numbers of regenerating neuritis, 
and the number of TUNEL-positives, caspase-9-, and apoptosis-inducing 
factor-immunopositive cells were significantly fewer than that in advanced 
glycation end-products without neurotrophin-4 media. The numbers of NF-
and SP1 immunopositive cells were increased in retinas exposed to AGEs than 
in control. Neurotrophic factors decreased the number of NF-
immunopositive cells, but did not significantly affect SP-1 expression.  
Neurotrophic factors increased the number of neurites, but more significantly in 
the NT-4 group.  
Conclusions: Our study showed that neurotoxic effect of low dose of AGEs were 
associated with increased expression of AIF and the active form of caspase-9. 
Also inhibition of of neurite regeneration in high-dose AGEs were correlated 
with increased expression of NFkB and Sp1. Neurotrophin 4 showed best 
neurorpotective and regenerative effect. 
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INTRODUCTION 
Advanced glycation end-products (AGEs) have been shown to accumulate in 
various tissues under diabetic conditions, and they participate in the 
development of vascular compli- cations such as diabetic retinopathy (Peppa et 
al., 2003).   
A key characteristic of certain reactive or precursor AGEs is their ability to form 
covalent crosslinks between proteins which alters their structure and function as 
occurs in cellular matrices, basement membranes, and vessel wall components 
(Peppa et al., 2003). Direct evidence that AGEs do affect tissues has been 
demonstrated by administration of AGEs prepared in vitro to normal rats which 
subsequently revealed the typical age: diabetes changes, basement membrane 
thickening, glomerular hypertrophy and an increase in the mesangial volume in 
the absence of hyperglycemia. The pathogenetic importance of the AGEs is 
found in most of the diabetes complications, which are grouped into micro- or 
macroangiopathies (Brownlee et al., 1988; Sell and Monnier, 1989; Dyer et al., 
1991; Ruderman et al., 1992; Wautier et al., 1994). AGEs affected cells from 
three main perspectives: as adducts occurring on modified serum proteins, as 
endogenous adducts formed as a consequence of glucose metabolism, and as 
extracellular matrix-immobilized modifications on long-lived structural proteins 
(Stitt, 2010).  
Increasing evidence showing that advanced glycation end-products 
(AGEs) are accumulated in various tissues under a diabetic condition, and they 
play an important role in the development of diabetic neuronal and vascular 
complications such as retinopathy (Ruderman et al, 1992, Wautier et al,1994).  
The human retinal study indicates that mitochondrial and caspase-dependent cell 
death pathway is associated with retinal neuronal cell degeneration in patients 
with diabetes (Oshitari et al,2005, Oshitai et al, 2005). Oshitari et al used 
three-dimensional retinal culture to examine the effect of several neurotrophic 
and/or survival factors on retinal neuronal cell death and regeneration. BDNF, 
NT-4, citicoline, VEGF120, VEGF164, and Taurine-conjugated ursodeoxycholic 
acid (TUDCA) had been tested. All factors showed survival effect of damaged 
retinal neurons induced by diabetic stress (Oshitari et al, 2003). Oshitari et al. 
found that NT-4 enhances significant neuroprotective effect in high glucose 
condition.  NT-4 promotes the survival and the regeneration of neuronal cells in 
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the retinas incubated in HG media (Oshitari et al, 2010).The results of an earlier 
study indicated that the maximum rescue ratio of caspase-1, -3, -8, and -9 
inhibitors in cultured retinas was 60% in damaged retinal ganglion cells (RGCs) 
(Oshitari and Adachi-Usami, 2003). Thus, at least 40% of neuronal cell death in 
damaged RGCs in cultured retinas should be related to caspase-independent cell 
death mechan- isms. However, no reports focus on caspase-independent cell 
death pathways under diabetic stress including AGE exposure.  
Apoptosis-inducing factor (AIF) is known to be the first mitochondrial protein 
in mediation cell death independent of caspase (Susin et al., 1996, 1999). It was 
characterized as a mitochondrial protein of intermembrane space of healthy cells. 
After permeabilization of the mitochondrial outer membrane, a feature of most 
if not all, apoptotic pathways (Green and Kroemer, 2004), AIF is released from 
the mitochondria and is translocated to the nucleus where it mediates the nuclear 
features of apoptosis such as chromatin condensation and large-scale (50 kb) 
DNA degradation (Susin et al., 1996, 1999). In healthy cells, AIF is a mitochon- 
drial flavin adenine dinucleotide which is dependent on oxidoreductase that 
plays roles in oxidative phosphorylation and redox control (Modjtahedi et al., 
2006).  
 AGEs conduct their effects by binding to specific cellular receptors (Vlassara 
et al, 1995, Schmidt et al,1994), as receptor of AGE (RAGE). They had been 
found on neurons, smooth muscle cells and endothelial cells (Schmidt et al, 
1994, Ritthaler et al, 1995).  Experimental evidence demonstrated that RAGEs 
depended modulation of gene expression and cellular properties depends on 
signal transduction. 
Specificity protein 1 (SP1) is a transcription factor that either activates or 
represses transcription in response to physiological and pathological stimuli. It 
regulates the expres- sion of a large number of genes involved in a variety of 
processes such as cell growth, apoptosis, differentiation, and immune responses 
(Infantino et al,2011). Several genes can be regulated by a combination of 
NF-𝜅B and SP1, and in specific cases by direct interaction between the NF-𝜅B 
protein and SP1 protein (Perkins et al,1992).  
Tanaka et al. 2000, found that AGEs can activate the RAGE gene through 
NF-𝜅B and SP1, causing enhanced AGE-RAGE interactions in human vascular 
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endothelial cells. They concluded that this activation can exacerbate diabetic 
microvas- culopathy. However, there are no reports demonstrating the 
relationship between NF-𝜅B/SP1 expression and regeneration in AGE exposed 
retinal neurons.  
 
MATERIALS AND METHODS 
Experimental Procedures 
Animals 
Seven-week-old male Sprague-Dawley (SD) rats (Japan SLC Co., Hamamatsu, 
Japan) were used.  All of the procedures were performed in accordance with 
the ARVO Statement for the Use of Animals in Ophthalmic and Vision 
Research.  
 
Three-dimensional collagen gel culture of rat retinal explants 
Twelve SD rats were killed by an overdose of ether.  The retinas were isolated 
under sterile conditions, and cut into square pieces of 0.16 mm2 with a sharp 
razor blade.  Then the retinal explants were three-dimensionally cultured on 
collagen gels as described [16-21].  Retinal explants of 12 adult SD rats were 
three-dimensionally cultured in collagen gel, and incubated in (1) serum-free 
control culture media, (2) 10 μg/ ml glucose-AGE-BSA (CycLex Co., Ltd., 
Nagano, Japan) media, (3) 10 μg/ml glycolaldehyde-AGE-BSA (CycLex Co) 
media, (4) 10 μg/ml glyceraldehyde-AGE-BSA (CycLex Co.) media, (5) 10 
μg/ml glucose-AGE-BSAþ100 ng/ml NT-4 (R and D Systems, Minneapolis, 
MN) media, (6) 10μg/ml glycolaldehyde-AGE- BSAþ100 ng/ml NT-4 media, 
(7) 10 μg/ml glyceraldehyde-AGE- BSAþ100 ng/ml NT-4 supplemented culture 
media, (8) 100 ng/ ml NT-4 supplemented media without AGE-BSA, or (9) 10 
μg/ml glucose-AGE-BSAþ 2 μM caspase-9 inhibitor (Z-LEHD-FMK; WAKO, 
Osaka, Japan) supplemented culture media. The 10 μg/ml glycated BSA was 
selected to investigate the effect of a very low dose of AGEs on neurite 
regeneration. For examining the dose- dependent effect of each AGE-BSA on 
neuronal cell death and neurite regeneration, (9) 100 μg/ml glucose-AGE-BSA, 
(10) 100 μg/ml glycolaldehyde-AGE-BSA, or (11) 100 μg/ml 
glyceraldehyde-AGE- BSA were incubated in serum-free media. To investigate 
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the neurotprophic effect of different neurotrophic factors (12) glucose +100 
ng/ml neurotrophin 4 (NT-4) media; (13) glucose +100 ng/ml hepatocyte growth 
factor (HGF) (R & D systems) media; (14) glucose +100 ng/ml glial cell line 
derived neurotrophic factor (GDNF) (R & D systems) media; or (15) glucose 
+100 ng/ml tauroursodeoxycholic acid (TUDCA) (WAKO, Osaka, Japan) media 
were studied. The number of regenerating neurites was counted under a 
phase-contrast microscope after 7 days of culture. The explants were 
immunostained for caspase-9, AIF, NFkB, SP1 after 7 days of culture.  
The explants were maintained at 37º C and exposed to 5% CO2.  The 
serum-
putrescine, 10% bovine serum albumin, 3.7 mg/ml NaHCO3, 5.2 mg/l Na2SeO3, 
and 3.6 mg/ml HEPES in minimum essential medium as described  (Oshitari et 
al, 2010, Takano et al, 1999, Oshitari et al, 2002a, Oshitari et al, 2011).  No 
additional albumin was used for the control medium except for the addition of 
glycated BSA because AGE-BSA was included only 10% of the total BSA in the 
culture media. 
 
TUNEL staining 
To determining whether apoptosis had occurred, the retinal explants were fixed 
in 4% paraformaldehyde after 7 days in culture and sectioned on a cryostat.  
Then TdT-dUTP terminal nick-end labeling (TUNEL) staining was carried out 
with an apoptosis detection kit (Chemicon International, Temecula, CA) 
according to the manufacturer’s instructions.  Non-specific signals were 
detected by omitting the enzyme reaction.  Sections were co-stained with 4, 
6-diamidino-2-phenyl indole (DAPI, Polyscience Inc., Warrington, PA).  For 
quantitative analyses, the ratio of the number of TUNEL-positive cells to the 
total number of DAPI-staining nuclei in the ganglion cell layer (GCL) was 
determined.  A total of 18 sections from the 6 explants/group were studied and 
the results were used for the statistical analyses.  Total numbers of nucleus 
counted were: 182 (N), 298 (AGEs), 287 (NT-4), 243 (HGF), 265 (GDNF), 256 
(TUDCA) for caspase-9 and AIF study. The total number of nuclei counted was 
405 (N), 215 (N + A), 816 (AGEs), 472 (NT-4), 396 (HGF), 512 (GDNF), and 
494 (TUDCA) for NFkB and SP1 study.  
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Immunohistochemistry 
The retinal explants were fixed as described and cryosections cut.  After 
blocking the sections in 5% goat serum and 3% bovine serum in 0.1 M 
phosphate buffer saline, they were incubated with rabbit anti-active form of 
caspase-9 of rabbit anti-apoptosis-inducing factor (AIF) antibodies and  rabbit 
anti-phosphorylated NF-𝜅B (p-NF-𝜅B) and SP1 transcription factor (Santa Cruz 
Biotechnology, Santa Cruz, CA) at 4º C overnight (24).  Then the sections 
were incubated with fluorescein isothiocyanate-conjugated anti-rabbit IgG for 
one hour.  Sections were co-stained with DAPI to make the nuclei visible.  
The number of AIF- and caspase-9 positive cells in the ganglion cell layer was 
counted.  For quantitative analyses, the number of immunopositive cells in the 
ganglion cell layer was expressed relative to the total number of DAPI-stained 
nuclei.  Eighteen sections were used from the 6 explants/group. Total numbers 
of nucleus counted were: 321 (N), 372 (AGEs), 269 (NT-4), 272 (HGF), 212 
(GDNF), 286 (TUDCA) for caspase – 9 and AIF study. The total number of 
nuclei counted was 301 in N, 234 in AGEs, 198 in NT-4, 254 in HGF, 186 in 
GDNF, and 276 in TUDCA for NFkB and SP1 study.  
 
Assessment of regenerating neurites 
The number of neurites regenerating from the explants was counted under a 
phase-contrast microscope after 7 days in culture when the number of 
regenerating neurites was very high.  Branched neurites were counted as one.  
The number of explants examined was 37 in the control group, 36 in the 
glucose-AGE-BSA group, 35 in the glycolaldehyde-AGE-BSA group, 36 in the 
glyceraldehyde-AGE-BSA group, 19 in the glucose-AGE-BSA+NT4, 20 in the 
glycolaldehyde-AGE-BSA+NT4, and 23 in the glyceraldehyde-AGE-BSA+NT4 
groups for caspase- 9 and AIF study. The number of explants examined was 101 
in the control group including that in serum-free media (N, N + A, N + NT- 4, 
N+HGF,N+GDNF,N+TUDCA), in the glucose- AGE-BSA group, 19 in the 
glycolaldehyde-AGE-BSA group, 18 in the glyceraldehyde-AGE-BSA group, 
14 in the glucose- AGE-BSA + NT-4, 12 in the glycolaldehyde-AGE-BSA + 
NT- 4, and 11 in the glyceraldehyde-AGE-BSA + NT-4 groups, 12 in the 
glucose-AGE-BSA + HGF, 14 in the glycolaldehyde- AGE-BSA + HGF, 13 in 
the glyceraldehyde-AGE-BSA + HGF groups, 12 in the glucose-AGE-BSA + 
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GDNF, 13 in the glycolaldehyde-AGE-BSA + GDNF, 14 in the glyceraldehyde- 
AGE-BSA + GDNF groups, 10 in the glucose-AGE-BSA + TUDCA, 11 in the 
glycolaldehyde-AGE-BSA + TUDCA, and 10 in the glyceraldehyde-AGE-BSA 
+ TUDCA groups for NFkB and SP1 study.  
 
Statistical analyses were carried by one-way ANOVA with Scheffe’s F tests.  A 
P <0.05 was considered significant. 
 
 
RESUTLS 
 
 
Detection of apoptosis 
To determine the effect of low dose AGEs and NT-4 on the retinas in culture, the 
number of TUNEL positive cells in the ganglion cell layer was counted.  The 
majority of the TUNEL-positive cells was detected in the ganglion cell layer 
because all of the RGCs were axotomized to isolate the retina (Horie et al, 1994, 
Oshitari et al,2002a, Oshitari et al, 2002b).  In retinas cultured in 
glucose-AGE-BSA, glycolaldehyde-AGE-BSA, and glyceraldehyde-AGE-BSA, 
the number of TUNEL-positive cells in the ganglion cell layer was significantly 
higher than that in the serum-free control medium (48.6 ± 10.5% vs. 11.8 ± 
6.3%, P <0.0001; 44.9 ± 9.9% vs. 11.8 ± 6.3%, P <0.0001; and 44.2 ± 10.6% vs. 
11.8 ± 6.3%, P <0.0001, respectively).  Addition of NT-4 to the AGEs-exposed 
retinas decreased the number of TUNEL-positives cells in the 
glucose-AGE-BSA medium without NT-4 (17.9 ± 7.3% vs. 48.6 ± 10.5%, P 
<0.0001) more than in glycolaldehyde-AGE-BSA without NT-4 (26.6 ± 10.7% 
vs. 44.9 ± 9.9%, P = 0.005), and in glyceraldehyde-AGE-BSA without NT-4 
(21.8 ± 4.1% vs. 44.3 ± 10.6%, P = 0.0003). 
 
Caspase-9 immunopositivity in ganglion cell layer (GCL) 
To determine whether caspase-9 was associated with the AGEs-induced 
neuronal cell death, the sections were immunostained for the active-form of 
caspase-9.  In retinas cultured with glucose-AGE-BSA, 
glycolaldehyde-AGE-BSA, and glyceraldehyde-AGE-BSA, the number of 
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active-form of caspase-9 immunopositive cells was significantly higher than in 
serum free control medium (25.3 ± 4.4% vs. 7.5 ± 4.4%, P <0.0001; 28.3 ± 
3.6% vs. 7.5 ± 4.4%, P <0.0001; 27.3 ± 6.5% vs. 7.5 ± 4.4%, P <0.0001).  
Addition of  NT-4 to the AGEs-exposed retinas decreased the number of 
caspase-9-immunopositives cells in glucose-AGE-BSA without NT-4 (4.4 ± 
1.1% vs. 25.3 ± 4.4%, P <0.0001), more than in glycolaldehyde-AGE-BSA 
without NT-4 (4.9 ± 2.7% vs. 28.3 ± 3.6%, P <0.0001) and in 
glyceraldehyde-AGE-BSA without NT-4 (7.5 ± 3.1% vs. 27.3 ± 6.5%, P 
<0.0001). 
 
Apoptosis-inducing factor (AIF) immunopositivity in ganglion cell layer  
The sections were immunostained for AIF to examine the association of AIF 
with AGEs-induced neuronal cell death.  In retinas cultured with 
glucose-AGE-BSA, glycolaldehyde-AGE-BSA, and glyceraldehyde-AGE-BSA, 
the number of AIF immunopositive cells was significantly higher than in 
serum-free control medium except for glyceraldehyde-AGE-BSA (44.7 ± 17.5% 
vs. 21.2 ± 11.4%, P =0.0004; 45.0 ± 14.9% vs. 21.2 ± 11.4%, P = 0.0002; 37.9 ± 
14.8% vs. 21.2 ± 11.4%, P = 0.056).  Addition of NT4 to the AGEs exposed 
retinas decreased the number of immunopositives cells in the glucose-AGE-BSA 
without NT-4 (21.0 ± 7.3% vs. 44.7 ± 17.5%, P=0.026) more than in 
glycolaldehyde-AGE-BSA without NT-4 (17.0 ± 6.1% vs. 45.0 ± 4.9%, P = 
0.026) and in glyceraldehyde-AGE-BSA without NT-4 (18.3 ± 5.3% vs. 37.9 ± 
14.8%, P = 0.016).  
 
p-NF-𝜅B Immunopositivity in Ganglion Cell Layer.  
The sections were immunostained for p-NF-𝜅B to determine whether NF-𝜅B 
was activated in retinas exposed to AGEs. The effects of the neurotrophic 
factors on the activation of NF-𝜅B were also examined. In retinas cultured with 
glucose- AGE-BSA, the number of p-NF-𝜅B immunopositive cells was higher 
than in serum-free control medium (53.2±7.2% versus 31.6 ± 16.1%; 𝑃 = 
0.0146; Figures 2 and 3). Addition of NT-4 decreased the number of 
immunopositive cells more than in the serum-free media (11.3 ± 6.9% versus 
31.6 ± 16.1%; 𝑃 = 0.0315) and more than in glucose-AGE-BSA without NT-4 
(31.5 ± 5.3% versus 53.2 ± 7.2%; 𝑃 = 0.0133; Figures 2 and 3). Addition of 
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HGF decreased the number of immunopositive cells more than in serum-free 
media (26.8 ± 5.3% versus 31.6 ± 16.1%; 𝑃 = 0.049) and in glucose-AGE- BSA 
without HGF (42.6±2.7% versus 53.2±7.2%; 𝑃 = 0.0114; Figures 2 and 3). 
Addition of GDNF decreased the number of immunopositive cells more than in 
serum-free media (13.3 ± 5.0% versus 31.6 ± 16.1%; 𝑃 = 0.0495) and in 
glucose- AGE-BSA without GDNF (25.8 ± 5.3% versus 53.2 ± 7.2%; 𝑃 = 
0.0011). Addition of TUDCA decreased the number of immunopositive cells 
more than in serum-free media (18.6 ± 3.97% versus 31.6 ± 16.1%; 𝑃 = 0.0024) 
and in glucose-AGE-BSA without TUDCA (36.2 ± 7.2% versus 53.2 ± 7.2%; 𝑃 
= 0.0034; Figures 2 and 3).  
 
SP1 Immunopositivity in Ganglion Cell Layer.  
The sec- tions were immunostained for SP1 transcription factor to determine 
whether it was expressed in retinas exposed to AGEs. We also examined the 
effect of neurotrophic factors on the expression of SP1 transcription factor. In 
retinas cultured with glucose-AGE-BSA, the number of SP1 immunopositive 
cells was higher than in serum-free control medium (32.2 ± 6.8% versus 6.3 ± 
1.2%; 𝑃 < 0.0001; Figures 4 and 5). Addition of NT-4 increased the number of 
immunopositive cells more than in serum-free media (13.0 ± 4.3% versus 6.3 ± 
1.2%; 𝑃 = 0.0315) but did not decrease the number of immunopositive cells in 
glucose-AGE-BSA without NT-4 (30.2 ± 8.4% versus 32.2 ± 6.8%; 𝑃 = 0.6753; 
Figures 4 and 5). Addition of HGF increased the number of immunopositive 
cells more than in serum-free media (19.7 ± 5.16% versus 6.3 ± 1.2%; 𝑃 = 
0.0001) but did not decrease the number of immunopositive cells in 
glucose-AGE-BSA without HGF (24.0 ± 6.7% versus 32.2 ± 6.8%; 𝑃 = 0.0926; 
Figures 4 and 5). Addition of GDNF increased the number of immunopositive 
cells more than in the serum-free media (12.3 ± 1.4% versus 6.3 ± 1.2%; 𝑃 < 
0.0001) but it decreased compared to in glucose-AGE-BSA without GDNF 
(19.7 ± 6.4% versus 32.2 ± 6.8%; 𝑃 = 0.0007; Figures 4 and 5). Addition of 
TUDCA increased the number of immunopositive cells more than in serum-free 
media (10.2 ± 3.9% versus 6.3 ± 1.2%; 𝑃 = 0.0454) but it decreased compared 
to in glucose-AGE-BSA without TUDCA (19.5 ± 5.5% versus 32.2 ± 6.8%; 𝑃 = 
0.0075)  
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Regenerating neuritis  
The number of regenerating neurites with growth cones were counted after 7 
days in culture.  In retinas incubated with glucose-AGE-BSA, 
glycolaldehyde-AGE-BSA, and glyceraldehyde-AGE-BSA, the number of 
regenerating neurites was significantly fewer than in retinas without AGE (68.6 
± 4.7/mm2 vs 30.8 ± 4.5/mm2, P = 0.0033; 68.6 ± 4.7/mm2 vs. 31.3 ± 5.7/mm2, 
P = 0.0044; 68.6 ± 4.7/mm2 vs. 31.8 ± 3.7/mm2, P = 0.0238).  In AGEs 
exposed retinas supplemented with NT-4, the number of regenerating neurites 
was significantly higher than in glucose-AGE-BSA without NT-4 (210.0 ± 
26.3/mm2 vs. 30.8 ± 4.5/mm2, P <0.0001), in glycolaldehyde-AGE-BSA without 
NT-4 (193.8 ± 24.1/mm2 vs. 31.3 ± 5.7/mm2, P <0.0001), and in 
glyceraldehyde-AGE-BSA without NT-4 (168.8 ± 10.6/mm2 vs. 31.8 ± 3.7/mm2, 
P <0.0001).  
 
 
DISCUSSION 
 
The connection of AGEs accumulation and development of diabetic 
complications had been shown in animal models with two unrelated AGE 
inhibitors partially prevented some functional and structural changes in retina, 
neuronal tissue and kidneys in diabetes. These responses include inappropriate 
expression of important enzymes of structural proteins and growth factors, 
induction of tumor necrosis factor-
cellular growth dynamics and migration, glial activation, accumulation of 
extracellular matrix molecules, promotion of vasoregulatory dysfunction, 
induction of oxidative cascades, and initiation of cell death pathways.  There 
has been an increasing number of reports that confirmed a widespread AGE 
accumulation at different sites in different ocular abnormalities.  In addition, 
there have been various in vitro and in vivo studies that have examined the 
possible pathophysiological role of AGEs in retinal cell dysfunction (Tezel, 
2007).   
 
The AGEs have been shown to accumulate in the diabetic retina (Hammes et 
al,1999) and optic nerve head (Amano et al, 2001) and have been detected in 
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eyes with retinopathies (Stitt et al, 2000, Treins et al,2001).  Recent studies 
(Hammes et al,1998, Leciere Collet et al, 2005) showed that AGEs 
concentrations of 100 μg/ml and 250 μg/ml were neurotoxic, and they also 
increased the retinal expression of vascular endothelial growth factor (VEGF) 
(Lu et al, 1998).   
 
Our results showed that even a low concentration of AGEs, e.g., 10 μg/ml, 
induces neuronal apoptosis in the ganglion cell layer and decreases the number 
of regenerated neurites.  The results of an earlier study showed that between 1 
circulating in diabetic patients (Ono et al, 1998).  Thus, the accumulation of 
AGEs in the retina could induce neuronal apoptosis in diabetic retinas more 
easily than in normal retinas.  Endogenous neurotrophic factors such as VEGF 
are also up-regulated in diabetic patients. Thus, the imbalance between the 
endogenous neurotrophic factors and the toxic effect of the AGEs may cause 
retinal neuronal death in eyes with diabetic retinopathy.   
 
Several clinical trials have demonstrated that anti-VEGF therapies are helpful in 
the treatment of diabetic macular edema (Frampton et al, 2012, Parravano et al, 
2009).  However, these studies did not evaluate the neuronal damage after 
repeated intravitreal injections of anti-VEGF drugs in diabetic patients.  Our 
data demonstrate a possible adverse effect of anti-VEGF therapies on damaged 
retinal neurons for patients with diabetic retinopathy. 
 
Our results also demonstrated that both caspase-dependent and 
caspase-independent cell death pathways are associated with the retinal neuronal 
death in AGE-BSA exposed rat retinas.  The majority of the cells that were 
immunopositive to AIF was detected in the nucleus of the ganglion cell layer in 
cultured retinas.  These results show that AIF is translocated into the nucleus 
and may be involved in DNA fragmentation and chromatin condensation during 
the process of apoptosis in AGE-BSA exposed rat retinas.  The active-form of 
caspase-9 was also detected mainly in the nucleus, and thus, both AIF and 
caspase-9 are translocated into the nucleus during the process of apoptosis in 
cultured retinas.  Although caspase-9 is known to cleave Ring1B, one of the 
polycomb group proteins in the nucleus (Wong et al, 2007), further studies are 
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needed to determine the precise role of AIF and caspase-9 in the nucleus during 
the process of apoptosis in AGE-BSA exposed retinal neurons. 
 
Finding a way to decrease the impact of the AGEs on the retina is important, and 
anti-AGEs drugs are now being intensively studied.  Aminoguanidine is an 
inhibitor of glycation reactions, and animal studies have shown that it was 
possible to inhibit the conversion of early products to AGEs (Gul et al, 2008).  
In addition, aminoguanidine has been evaluated in a multicenter clinical trial but 
it failed to lower the serum creatinine and urinary albumin significantly but had 
a positive trend toward slowing the progression of overt nephropathy and 
retinopathy (Bolton et al, 2004).  Pyridoxamine (Pyridorin; NephroGenex, 
Princeton, NJ), a derivative of vitamin B6, was described as an efficacious and 
specific post-amadori inhibitor that reduces the accumulation of retinal AGEs 
and attenuates the up-regulation of the basement membrane-associated genes 
and capillary acellularity in diabetic rat retinas (Voziyan et al, 2002).  More 
recently, LR-90 was shown to be an effective multistage inhibitor of AGEs 
formation with an associated renoprotective and anti-inflammatory potential 
(Rahbar et al, 2007).  AGEs cross-link breakers were described as attackers of 
AGEs-derived protein crosslinking, and treatment with this drug reduced 
vascular stiffening in experimental diabetes (Vasan et al, 2003).  The effects of 
AGEs breakers on diabetic retinopathy have yet to be evaluated.  The results of 
preliminary experimental studies suggested that AGEs formation and activation 
of AGEs-receptors represent important, interconnected pathogenic mechanisms 
in diabetic retinopathy.  Thus, inhibition of these pathways could be a valid 
avenue for therapeutic exploitation. 
 
Our study demonstrated that NT-4 reduced the retinal neuronal apoptosis 
induced by AGEs and increased the number of regenerated neurites. The 
neuroprotective and regenerative effects of NT-4 were correlated with the 
reduction of caspase-9 and activation or AIF.  The results indicate that NT-4 is 
an endogenous neurotrophic factor that protects retinal neurons from injury and 
is neuroprotective as well as neuroregenerative in the retina.  Further studies 
are needed to determine the precise mechanism of how NT-4 promotes neuronal 
survival and regeneration under AGEs stress. 
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NF-𝜅B is a primary transcription factor that plays an important role in regulating 
cellular responses, that is, a transcription factor that is present in cells in an 
inactive state and does not require new protein synthesis to become activated. 
Other members of this family include transcription factors such as c-Jun, STATs, 
and nuclear hormone receptors. This allows NF-𝜅B to be the first responder to 
toxic cellular stimuli. Some aspects of the mechanism by which NF-𝜅B protects 
cells against toxins have been identified. For example, tumor necrosis factor-𝛼 
has been shown to protect hippocampal neurons against excitatory amino acid 
toxicity through NF- 𝜅B activation by inducing Bcl-2 and Bcl-x expression 
(Tamatani et al.1998)  
SP1 transcription factor belongs to a group of factors that are associated with 
GC-rich promoters that are involved in basal promoter activity. SP1 regulates 
the expression of different genes, including the vascular endothelial growth 
factor, fibrogenic cytokine, and many matrix genes (Yoshida-Hata et al, 2010). 
Several studies reported that the interactions between AGE and RAGE cause 
phenotypic changes in the microvascular endothelial cells and pericytes 
(Yamagishi et al.,1995,1996,1998) It was shown that upregulations of RAGEs 
are mediated by NF-𝜅B and SP1 [(Tanaka et al, 2000).  
Our results showed that AGEs increase the expression of the transcription factor 
NF-𝜅B and SP1 in retinal neu- rons. This suggests that AGEs enhanced the 
expression of the RAGEs gene in retinal neurons through the increased 
expression of NF-𝜅B and SP1. An upregulation of NF-𝜅B and SP1 proteins in 
retinal neurons suggests that different protective mechanisms are important for 
the protection of these cells against AGEs-mediated cell death.  
TUDCA is a member of a group of compounds that modulate the endoplasmic 
reticulum (ER) function, pro- tecting the cells against ER stress-induced 
apoptosis (Zhang et al, 2012) 
Earlier studies showed that TUDCA had protective effects on damaged retinal 
neurons under diabetic stress as an anti-ER reagent.  
HGF is a strong survival factor for developing and injured adult hepatocytes. It 
is also a potent mitogen and differentiation factor for endothelial cells 
(Borowiak et al,2004), and it had neurotrophic and neuroprotective activity for 
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central nervous system neurons (Gizcobini et al,2007, Helmbacher et al,2003). 
Tonges et al. 2011 used an optic nerve axotomy model and demonstrated that 
HGF prevented RGC apoptosis in vivo in a concentration-dependent manner. 
This validated the beneficial role of HGF for retinal neurons. Also Wong et al. 
2014, found that HGF promoted long-term survival and axonal regeneration of 
RGC after optic nerve injury.  
Recently, GDNF was found to be a growth and survival factor for neuronal cells, 
and it promoted the survival of peripheral sensory and sympathetic neurons and 
also motor neurons (Trupp, 1996). Koeberle and Ball,1998 studied the effects of 
GDNF on RGC survival and apoptosis after optic nerve transection. They 
suggested that GDNF aided in the survival of RGCs after axotomy.  
NT-4 is a member of the nerve growth factor family which acts on different 
types of nerve cells, for example, sensory, cortical, and hippocampal neurons. It 
also acts on basal forebrain cholinergic nerve cells. Our results showed that 
NT-4 promoted the survival and the regeneration of neuronal cells in the retinas 
incubated in high glucose media.  
The results of the present study showed that all examined neurotrophic factors 
decreased the number of NF-𝜅B immunopositive cells in glucose-AGE-BSA 
exposed retina, but NT-4 had the highest significant effect. However, the 
number of SP1 immunopositive cells was increased by the addition of 
neurotrophic factors in serum-free media and more significantly in the HGF and 
NT-4 groups. Thus after the addition of neurotrophic factors to 
glucose-AGE-BSA media, the level of SP1 transcription factor remained high in 
the NT-4 and HGF group. However, there was a slight decrease in the GNDF 
and TUDCA groups.  
Kanda et al. found that prostaglandin E2 promoted innervation in skin lesions by 
the induction of NT-4, and the induction was mediated by SP1 (Kanda et 
al,2005). Their results showed that the EP3, G-protein-coupled receptors, 
mediated by prostaglandin E2 transcription of NT-4 was dependent on the 
activity of SP1. Thus, our findings suggest that SP1 may be related to neuronal 
survival and regeneration. Human NT- 4 promoter has not been completely 
characterized. However, it may have several SP1-binding sites because antisense 
SP1 suppressed NT-4 expression (Salin et al, 1997)  
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It is possible that the increased expression of SP1 may result from an enhanced 
phosphorylation of SP1, because the SP1 promoter contains several SP1-binding 
elements and is positively regulated by its own gene product, SP1 protein 
(Nikolas et al,2001). Further studies are needed to identify the connection 
between SP1 expression and NT-4 transcription.  
To find a possible decrease in the effect of the AGEs on the retina is important. 
Our findings that a suppression of NF-𝜅B expression in retinal neurons by 
several neurotrophic factors can result in neuroprotection, and reducing 
inflammation and oxidative stress suggests therapeutic potential of neuro- 
protective therapy in various ocular pathologies associated with AGEs 
accumulation.  
 
CONCLUSION 
 
 
The AGEs are neurotoxic and inhibit regeneration of neuritis of retinal neurons 
even at low concentrations.  The neurotoxic effect of AGEs is associated with 
increased expression of AIF and the active-form of caspase-9.  NT-4 
significantly enhances neurite regeneration in retinas exposed to AGE.  The 
neuroprotective and regenerative effects of NT-4 are correlated with the 
reduction of caspase-9 and AIF expression. Further investigations to determine 
the mechanism(s) of AGEs on retinal neurons are needed.  
High-dose AGEs inhibit neurite regeneration which is correlated with increased 
expression of NF- 𝜅B and SP1. NT-4 enhances neurite regeneration in AGEs 
exposed retinas more than other neurotrophic factors such as HGF, GDNF, and 
TUDCA. This effect of NT-4 is correlated with NF-𝜅B suppression. SP1 
overexpression may be related to neuronal regeneration in neurotrophic factors 
incubated retinas. Our results indicate the therapeutic potentials of the 
neurotrophic factors as axoprotectants in AGEs exposed retinas.  
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FIGURES: 
 
Figure 1. Representative photographs of regenerating neurites. Regenerating 
neurites are seen under phase-contrast microscopy. In the control serum-free media 
(a) neurites with normal length are present. In retinas cultured in glucose-AGE-BSA 
(b), glyceraldehyde-AGE- BSA(c), and glycolaldehyde-AGE-BSA (d), the neurites 
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were shorter, and the numbers of neurites were fewer. In AGEs exposed retinas 
supplemented with NT-4 (glucose-AGE-BSA + NT-4 (e), glyceraldehyde-AGE-BSA + 
NT-4 (f), and glycolaldehyde-AGE-BSA + NT-4 (g)), the neurites are longer and 
thicker, and the number of neurites are higher even than in serum-free control media 
(a). In AGEs exposed retinas supplemented with HGF, GDNF, and TUDCA 
(glucose-AGE-BSA + HGF (h), glyceraldehyde-AGE-BSA + HGF (i), and 
glycolaldehyde- AGE-BSA + HGF (j)), (glucose-AGE-BSA + GDNF (k), 
glyceraldehyde-AGE-BSA + GDNF (l), and glycolaldehyde-AGE-BSA + GDNF (m)), 
(glucose-AGE-BSA + TUDCA (n), glyceraldehyde-AGE-BSA + TUDCA (o), and 
glycolaldehyde-AGE-BSA + TUDCA (p)), the neurites are longer and thicker than in 
AGEs exposed retina.
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Figure 2. Graph showing the number of regenerating neurites in all groups. N: serum-free media, G: glucose-AGE-BSA; Glycol: 
glycolaldehyde-AGE-BSA; Glycer: glyceraldehyde-AGE-BSA; NT- 4: neurotrohin-4; H: hepatocyte growth factor; G: glial cell line- derived 
neurotrophic factor; T: tauroursodeoxycholic acid.  
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Figure 3. Representative photomicrographs of TUNEL-positive cells in the GCL 
of isolated rat retinas. In retinas cultured in glucose-AGE-BSA (C), 
glyceraldehyde-AGE-BSA (E), glycolaldehyde-AGE-BSA (G) and high-dose 
glucose-AGE-BSA (I), the numbers of TUNEL-positive cells in the GCL were 
significantly higher than in serum-free control media (A). In AGEs exposed 
retinas supplemented with NT-4 (glucose-AGE-BSAþNT4 (D), 
glyceraldehyde-AGE-BSAþNT-4 (F), glycolaldehyde-AGE- BSAþNT-4 (H)) and 
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in serum-free media with NT-4 (B), the numbers of TUNEL-positives cells were 
fewer than that in AGEs exposed retinas without NT-4 (C, E, and G). The blue 
staining shows the DAPI-stained nuclei. GCL: ganglion cell layer; INL: inner 
nuclear layer; ONL: outer nuclear layer. Bar1⁄420 μm.  
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Figure 4.Graph showing the ratio of TUNEL-positive cells to all cells in the GCL of retinal explants. N, serum-free media; G, glucose-AGE-BSA; 
Glycol, glycolaldehyde-AGE-BSA; Glycer, glyceraldehyde-AGE-BSA; NT-4, neurotrohin-4; H, hepatocyte growth factor; GN, glial cell line-derived 
neurotrophic factor; T, tauroursodeoxycholic acid.  
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Figure 5. Representative photomicrographs of caspase-9 immunopositive cells 
in the GCL of isolated rat retinas. In retinas cultured in glucose-AGE-BSA (C), 
glyceraldehyde-AGE-BSA (E), and glycolaldehyde-AGE-BSA (G), the numbers 
of TUNEL- positive cells in the GCL were significantly higher than in serum-free 
control media (A) and serum-free with NT-4 (B). In AGEs exposed retinas 
supplemented with NT-4 (glucose-AGE-BSA+NT-4 (D), 
glyceraldehyde-AGE-BSA+NT-4 (F), glycolaldehyde- AGE-BSA+NT-4 (H)), the 
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numbers of caspase-9-immunopositive cells were fewer than that in AGEs 
exposed retinas without NT-4 (C, E, and G). The blue staining shows the 
DAPI-stained nuclei. Bar- 20 μm.  
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Figure 6. Representative photomicrographs of AIF-immunopositive cells in the 
GCL of isolated rat retinas. In retinas cultured in glucose-AGE-BSA (C), 
glyceraldehyde-AGE-BSA (E), and glycolaldehyde-AGE-BSA (G), the numbers 
of AIF-immunopositive cells in the GCL were significantly higher than in 
serum-free control media (A) and serum-free media with NT-4 (B). In AGEs 
exposed retinas supplemented with NT-4 (glucose-AGE-BSA+NT-4 (D), 
 34 
glyceraldehyde-AGE-BSA+NT-4 (F), glycolaldehyde- AGE-BSA+NT-4 (H)), the 
number of AIF-immunopositive cells is fewer than that in AGEs exposed retinas 
without NT-4 (C, E, and G). The blue signals show the DAPI-stained nuclei. 
Bar-20 μm.  
 
 
 
Figure 7. Representative photomicrographs of caspase-9- and 
AIF-immunopositive cells in the GCL of retinas incubated with caspase-9 
inhibitor after 4 days in culture. In retinas exposed to low-dose 
glucose-AGE-BSA, the numbers of caspase-9- (B) and AIF-immunopositive cells 
(E) were significantly higher than in serum-free media (A and D, respectively). In 
caspase-9 inhibitor incubated retinas exposed to low-dose glucose-AGE-BSA 
(C), the number of caspase-9-immunopositive cells was significantly lower than 
in low-dose glucose-AGE-BSA exposed retinas without caspase-9 inhibitor (B). 
However, in glucose- AGE-BSA exposed retinas incubated with caspase-9 
inhibitor (F), the number of AIF-immunopositive cells was not significantly 
different from in low-dose glucose-AGE-BSA exposed retinas without caspase-9 
inhibitor (E). The blue signals show the DAPI-stained nuclei. Bar1⁄420 μm. 
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Figure 8. Graphical illustrations of caspase-9 (A) and AIF (B) immunopositivity in the 
GCL of retinal explants incubated with caspase-9 inhibitor after 4 days in culture. G_B: 
low-dose glucose-AGE-BSA; C9I: caspase-9 inhibitor; NS: not significant. **P<0.01 and 
***P<0.001.  
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Figure 9. Representative photomicrographs of NF-𝜅B immunopositive cells in 
the ganglion cell layer (GCL) of isolated rat retinas. In retinas cultured in 
glucose-AGE-BSA (f), the number of immunopositive cells in the ganglion cell 
layer is significantly higher than in serum-free control media (a). In AGEs 
exposed retinas supplemented with NT-4 (glucose-AGE-BSA + NT-4) (g), with 
HGF (glucose-AGE-BSA + HGF) (h), with GDNF (glucose-AGE-BSA + GDNF) 
(i), and with TUDCA (glucose-AGE-BSA + TUDCA) (j) the number of NF-𝜅B 
immunopositive cells is fewer than that in AGEs exposed retinas without 
neurotrophic factors. The blue staining shows the DAPI-stained nuclei. Panels 
(b), (c), (d), and (e) are pictures of the serum-free media supplemented with 
NT-4 (b), HGF (c), GDNF (d), and TUDCA (e). Bar = 20 𝜇m.  
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Figure 10. Graph showing the ratio of NF-𝜅B immunopositive cells to all cells in 
the GCL of retinal explants. N, serum-free media; G, glucose-AGE-BSA; Glycol, 
glycolaldehyde-AGE-BSA; Glycer, glyceraldehyde-AGE-BSA; NT-4, 
neurotrohin-4; HGF, hepatocyte growth factor; GDNF, glial cell line-derived 
neurotrophic factor; TUDCA, tauroursodeoxycholic acid.  
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Figure 11. Representative photomicrographs of SP1 immunopositive cells in the 
ganglion cell layer (GCL) of isolated rat retinas. In retinas cultured in 
glucose-AGE-BSA (f), the number of immunopositive cells in the ganglion cell 
layer is significantly higher than in serum-free control media (a). In AGEs 
exposed retinas supplemented with NT-4 (glucose-AGE-BSA + NT-4) (g), with 
HGF (glucose-AGE-BSA + HGF) (h), with GDNF (glucose-AGE-BSA + GDNF) 
(i), and with TUDCA (glucose-AGE-BSA + TUDCA) (j) the number of SP1 
immunopositive cells is higher than that in AGEs exposed retinas without 
neurotrophic factors. The blue signals show the DAPI-stained nuclei. Panels (b), 
(c), (d), and (e) show the representative pictures of the serum-free media 
incubated with NT-4 (b), HGF (c), GDNF (d), and TUDCA (e). Bar = 20 𝜇m.  
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Figure 12. Graph showing the ratio of SP1 immunopositive cells to all cells in the 
GCL of retinal explants. N: serum free media, G: glucose-AGE-BSA; Glycol: 
glycolaldehyde-AGE-BSA; Glycer: glyceraldehyde-AGE-BSA; NT-4: 
neurotrohin-4; HGF: hepatocyte growth factor, GDNF: glial cell line-derived 
neurotrophic factor; TUDCA: tauroursodeoxycholic acid.  
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